US Broker Ratings

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 46.55% Potential Upside

Encompass Health Corporation (NYSE: EHC) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. This Birmingham, Alabama-based company operates a network of inpatient..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a Promising 18.23% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector’s medical instruments and supplies industry, has been capturing investor attention with its innovative approach to orthodontic solutions and a..

Zoetis Inc. (ZTS) Stock Analysis: Potential 28% Upside Attracts Investor Attention

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, attracts investor interest with a market capitalization of $51.98 billion and an impressive potential upside of 28.03% based on..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A 25.73% Potential Upside Beckons Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), an established player in the healthcare sector, is poised to capture investor attention with a noteworthy potential upside of 25.73%, as indicated by its..

Elanco Animal Health (ELAN) Stock Analysis: Unpacking a 24.65% Potential Upside for Investors

Elanco Animal Health Incorporated (NASDAQ: ELAN) stands out in the healthcare sector as a key player in the animal health industry. With a market capitalization of $11.47 billion, Elanco is..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 33.72% Potential Upside for Investors

Revvity, Inc. (NYSE: RVTY) is making waves in the healthcare sector, particularly within the diagnostics and research industry. Formerly known as PerkinElmer, Inc., the company rebranded in April 2023, continuing..

argenx SE (ARGX) Stock Analysis: A 36% Potential Upside Beckons in the Biotech Sector

For investors eyeing opportunities in the booming biotechnology sector, argenx SE (NASDAQ: ARGX) presents a compelling case. With a market capitalization of $46.32 billion, this Netherlands-based biopharmaceutical company specializes in..

Masimo Corporation (MASI) Stock Analysis: Evaluating Growth and Market Position in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI) remains a noteworthy player in the healthcare sector, specifically within the medical devices industry. Based in Irvine, California, Masimo specializes in patient monitoring technologies and connectivity..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a Potential 73.67% Upside in the Healthcare Sector

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare information services industry, offers digital tools that empower medical professionals across the United States. With a market capitalization of $4.29..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Exploring a 60.13% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a key player in the biotechnology sector, is making headlines with its impressive growth potential. With a market capitalization of $10.67 billion, BioMarin focuses on..

Henry Schein, Inc. (HSIC) Investor Outlook: Exploring a Potential 21.72% Upside in the Healthcare Sector

Henry Schein, Inc. (HSIC), a stalwart in the healthcare sector, has carved a niche in the medical distribution industry, providing a comprehensive array of health care products and services to..

Guardant Health, Inc. (GH) Investor Outlook: A 39% Potential Upside Beckons

Guardant Health, Inc. (NASDAQ: GH) is making waves in the healthcare sector with its innovative approach to precision oncology. Specializing in diagnostics and research, this Palo Alto-based company is carving..

BeOne Medicines Ltd. (ONC): A Swiss Biotech Powerhouse with 31% Upside Potential

BeOne Medicines Ltd. (ONC), a prominent player in the global biotechnology sector, is capturing significant attention in the investment community. Based in Basel, Switzerland, this oncology-focused company has been making..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Pioneer with 31.94% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its focus on developing therapies for serious and rare diseases. As the company continues its journey in the healthcare..

Takeda Pharmaceutical Company L (TAK): Investor Outlook Reveals 9.63% Potential Upside and Strong Buy Ratings

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector and a prominent player in the specialty and generic drug manufacturing industry, presents a compelling investment case for..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 33% Potential Upside in the Healthcare Sector

Investors looking to diversify their portfolios with a solid player in the healthcare sector might find Baxter International Inc. (NYSE: BAX) an interesting prospect. With a market capitalization of $8.61..

Corcept Therapeutics (CORT): Investor Outlook Highlights Strong Upside Potential Amidst Robust Growth

Corcept Therapeutics Incorporated (NASDAQ: CORT) is capturing the attention of investors with its promising growth trajectory and significant upside potential. As a key player in the biotechnology sector, the company..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: Biotechnology Powerhouse With a 40.92% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, has captured investor attention with its cutting-edge therapeutics based on ribonucleic acid interference (RNAi). With a market capitalization of..

Charles River Laboratories Inte (CRL) Stock Analysis: Evaluating a 14.48% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector specializing in diagnostics and research, offers intriguing prospects for individual investors. With a market capitalization of..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Promising Growth Potential with a 24.85% Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading biotechnology company, has garnered significant attention in the healthcare sector. With a market capitalization of $111.45 billion, Vertex stands as a formidable player..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds